Sysmex (6869) · InitiativeRestated
Strategic Development of a KOL Network
First written in FY2021. 1 of 2 entries say "Restated". Latest entry: FY2024-Q1.
2entries
3years
0from disclosures
How it moved
Same theme, other companies
Strategic Development of a KOL NetworkA theme 1 companies write about · 0 as a headwind · 1 as a tailwind
No other company in this theme has enough history to compare yet.
Full recordFilings, disclosures and news, newest first
- FY2024-Q1RestatedAnnual report
「Going forward, to expand patients' access to medical consultations at an early stage, the company will promote collaboration with relevant academic societies and KOLs (Key Opinion Leaders), and pursue the inclusion of its products in diagnostic guidelines and activities aimed at obtaining reimbursement coverage.」
The company has restated its policy of using the KOL network in connection with expanding access to medical consultations for Aβ testing reagents, inclusion in diagnostic guidelines and activities aimed at obtaining reimbursement coverage. - FY2021First statedAnnual report
「In addition, to continuously create new clinical value in each business area and across business areas, the company will strategically build a KOL (Key Opinion Leader) network and strengthen collaboration.」
The company first outlined the development of a KOL network and stronger collaboration as means of creating new clinical value within and across business areas.